CVE ROE
21.02%TTM
Retrieved:
CVE FY ROE%
32.00%-21.74%
2008-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
CVE roe history
Return on equity. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.
| Period ending | ROE |
|---|---|
| 12.4281% | |
| 10.5599% | |
| 14.3181% | |
| 23.3899% | |
| 2.4877% | |
| -14.2395% | |
| 11.4265% | |
| -16.5388% | |
| 12.1515% | |
| -4.7023% | |
| 4.9875% | |
| 7.3041% | |
| 6.6559% | |
| 10.1265% | |
| 15.7134% | |
| 10.7863% | |
| 7.6883% | |
| 26.7994% |
Compare roe
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) roe
- HSBC Holdings, plc. Common Stock (HSBC) roe
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) roe
- Novartis AG Common Stock (NVS) roe
- Royal Bank Of Canada Common Stock (RY) roe
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) roe
- SAP SE ADS (SAP) roe
- AstraZeneca PLC Ordinary Shares (AZN) roe
Compare all covered stocks by roe →
All CVE financial metrics · CVE stock overview · How to interpret financial metrics